Product
Udonitrectag
1 clinical trial
1 indication
Indication
Neurotrophic KeratopathyClinical trial
Efficacy, Safety and Pharmacokinetics of 3 Doses of REC 0/0559 Eye Drops for the Treatment of Stage 2 (Moderate) and 3 (Severe) Neurotrophic Keratitis in Adult PatientsStatus: Recruiting, Estimated PCD: 2024-04-01